22 min listen
128 - Introducing HelixTalk’s 2021 Drug Superlative Awards!
FromHelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
128 - Introducing HelixTalk’s 2021 Drug Superlative Awards!
FromHelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
ratings:
Length:
47 minutes
Released:
Mar 30, 2021
Format:
Podcast episode
Description
In this episode, we announce the debut of the HelixTalk Drug Superlative Awards -- awards given to medications on the market that are outstanding or notorious. In announcing these completely fictitious awards, we review key clinical pearls and pitfalls that every clinician should be aware of with these medications. Key Concepts Drug most likely to be remembered for COVID-19 ineffectiveness rather than its actual FDA indication: hydroxychloroquine Commonly used but worst hypertensives on the market: it’s a tie! Atenolol and hydrochlorothiazide. Most confusing dosage forms: valproic acid, valproate sodium, and divalproex -- it’s all the same thing! Most innovative prodrug: valacyclovir Hottest inactive ingredient: it’s a tie! Sulfobutylether-beta-cyclodextrin (SBECD), an excipient in remdesivir, and polyethylene glycol (PEG), an excipient in mRNA vaccines.
Released:
Mar 30, 2021
Format:
Podcast episode
Titles in the series (100)
Top 200 Drugs - Sleep Agents and Neuropathic Pain: In this session of the RFUMS Top 200 Drugs Podcast, we discuss sleep agents and neuropathic pain: alprazolam, clonazepam, diazepam, lorazepam, zolpidem, zaleplon, gabapentin, pregabalin, and lidocaine. by HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast